IN THE SPOTLIGHT

Using T cells to Tackle Drug Resistance in EGFR+ Lung Cancer

Using T cells to Tackle Drug Resistance in EGFR+ Lung Cancer

Approximately 10%-15% of patients with non-small cell lung cancer have tumors with mutations in the EGFR (epidermal growth factor receptor) gene. EGFR mutations are known to drive cancer growth. Many patients living with EGFR-positive lung cancer benefit from targeted therapies called tyrosine kinase inhibitors (TKIs). TKIs, such as osimertinib, can help patients by specifically blocking the effect of these mutations and reducing tumor growth. However, TKI-treated tumors eventually develop drug…

AstraZeneca touts ‘overwhelming’ Tagrisso win among 3 lung cancer advancements

AstraZeneca touts ‘overwhelming’ Tagrisso win among 3 lung cancer advancements

AstraZeneca gets new Tagrisso OK as drug succeeds in another trial

AstraZeneca gets new Tagrisso OK as drug succeeds in another trial

Trial for AstraZeneca’s lung cancer drug Tagrisso points to increased survival rate

Trial for AstraZeneca’s lung cancer drug Tagrisso points to increased survival rate

AstraZeneca’s Tagrisso With Chemotherapy Gets FDA Approval for EGFR-Mutated Non-Small Cell Lung Cancer

AstraZeneca’s Tagrisso With Chemotherapy Gets FDA Approval for EGFR-Mutated Non-Small Cell Lung Cancer

Maintenance Osimertinib Demonstrates PFS Benefit in Stage III EGFR-Mutant NSCLC

Maintenance Osimertinib Demonstrates PFS Benefit in Stage III EGFR-Mutant NSCLC

FDA approves Tagrisso plus chemotherapy for EGFR-mutated non-small cell lung cancer

FDA approves Tagrisso plus chemotherapy for EGFR-mutated non-small cell lung cancer

AstraZeneca Expands Tagrisso’s NSCLC Label, FDA Allows Use with Chemo

AstraZeneca Expands Tagrisso’s NSCLC Label, FDA Allows Use with Chemo

FDA approves osimertinib with chemotherapy for EGFR-mutated non-small cell lung cancer

FDA approves osimertinib with chemotherapy for EGFR-mutated non-small cell lung cancer

Is Lung Cancer in Young Adults Hereditary?

Is Lung Cancer in Young Adults Hereditary?

Do you ever wonder if lung cancer runs in families?Join us for an interactive Facebook Live with guest speakers Gwen Orilio (patient advocate) and Dr. Jaclyn LoPiccolo (thoracic oncologist, Dana-Farber Cancer Institute) as they discuss what’s known about the link between genetics and lung cancer and why understanding these connections is important for patients and their families.Dr. LoPiccolo is the recipient of the 2023 Lung Cancer Initiative/LUNGevity Career Development Award. Her project…

Fertility Preservation and Cancer

Fertility Preservation and Cancer

Medications and treatments for lung cancer can affect fertility in both women and men. This video covers how to work with a reproductive endocrinologist, the first steps after getting your diagnosis, what to consider before starting treatment, and options after completing treatment.

Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib Resistant EGFR-Driven Lung Cancer

Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib Resistant EGFR-Driven Lung Cancer

Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review

Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review

Lung Cancer Masterclass: Get Smart About Lung Cancer

Lung Cancer Masterclass: Get Smart About Lung Cancer

In the past five years, the lung cancer community has seen an astonishing number of new treatments. As our understanding of lung cancer has deepened, the older treatment approaches have also become more effective and efficient.  These options are fantastic steps toward improving the overall survival and quality of life for people living with lung cancer, but it can be difficult for patients and caregivers to keep track of the new drug treatments and scientific advancements. …

Finding Balance in Life and Treatment with Marnie Clark

Finding Balance in Life and Treatment with Marnie Clark

The symptoms that led Marnie Clark to her doctor were unusual. Her leg was feeling “weird,” but it was more of an annoyance than something she was concerned about. Then came an issue she couldn’t ignore—her leg was paralyzed, and she couldn’t move it. “The doctor thought it had to be something physically wrong with my leg, but over the previous two years I started to take my health seriously and was working with a personal trainer. I was feeling strong, so it didn’t make sense that I had a…

HOPE Summit 2024 in Atlanta, GA

HOPE Summit 2024 in Atlanta, GA

Atlanta, GA

Registration is now open! Join us for this free event in Atlanta, GA, May 3-5, 2024 .HOPE Summit is a unique weekend conference for people living with lung cancer, survivors, and caregivers to learn how to manage and navigate aspects of everyday life with lung cancer while building their community of support. The conference features inspirational speakers and key experts on practical issues of cancer survivorship. Sessions will cover many of the issues patients, survivors, and…

Questions to Ask About Clinical Trials

Questions to Ask About Clinical Trials

Asking your doctor and medical team questions about clinical trials is a helpful way to decide if they are a good fit for you. You may already have some in mind, but a few basic questions to ask and get answered before making a decision are:Do you know of any clinical trials for my type and stage of lung cancer?What are the benefits and risks of this clinical trial?What are the eligibility guidelines?How long does the study last?Will you still be in charge of my care?What are the costs, and…

Clinical Trial Phases

Clinical Trial Phases

The four phases of lung cancer clinical trials each serve a different and important purpose. From testing the safety of a new treatment to its effectiveness and long-term outcomes, this short video explains how researchers use clinical trials for new lung cancer treatments.Phases of a Clinical Trial:1. Safety of the new treatment 2. Does the cancer respond to the treatment 3. Is this new treatment better than the current options 4. Studies the long-term benefits and side effects

Helpful Apps for People Living with Cancer

Helpful Apps for People Living with Cancer

As mobile apps become more ingrained in our lives, it’s natural to look for ones that can help manage a cancer diagnosis. As for which app to choose, it really comes down to what you’re looking for, what you’re comfortable with, and what fits your needs.  This list of helpful apps for people living with cancer includes ones that range from very basic, essentially a mobile pen and piece of paper, to all-in-one solutions that make medication tracking, document management, and…

Drs. Susumu Kobayashi and Alexandre Reuben Announced as Recipients of EGFR Resisters/LUNGevity Research Award

Drs. Susumu Kobayashi and Alexandre Reuben Announced as Recipients of EGFR Resisters/LUNGevity Research Award

LUNGevity Foundation is thrilled to announce the recipients of the EGFR Resisters/LUNGevity Research Award for EGFR-Positive Lung Cancer.EGFR Resisters, a vibrant patient-led community advocating for improved treatment options for patients with EGFR-positive lung cancer, has partnered with LUNGevity for the second time to support high-impact research focused on EGFR-positive lung cancer.“We are pleased to partner with LUNGevity again on patient-directed research to address the unmet needs of…

LUNGevity Announces $1.2M in Lung Cancer Workforce Development Research Awards

LUNGevity Announces $1.2M in Lung Cancer Workforce Development Research Awards

LUNGevity Foundation is proud to announce the recipients of four awards to bolster the lung cancer research workforce— the Career Development Award, the VA Research Scholar Award, the Health Equity and Inclusiveness Research Fellow Award, and the ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant.“Progress in lung cancer research is only possible with a vibrant and diverse thoracic oncology workforce,” notes Upal Basu Roy, PhD, MPH, executive director, LUNGevity Research. “We…

Finding (Mental) Peace this Holiday Season

Finding (Mental) Peace this Holiday Season

The holidays are stressful enough without having to deal with lung cancer. LUNGevity is here to help.This discussion of the mental health challenges we face in the lung cancer community includes strategies for coping with a lung cancer diagnosis, stigma, and holiday anxiety. With the daylight getting shorter, we also discuss tips to address seasonal affective disorder. The free support programs and services available through LUNGevity for patients and caregivers are highlighted.This webinar…

Treatment & Research Takeaways: ESMO 2023 Meeting

Treatment & Research Takeaways: ESMO 2023 Meeting

The European Society for Medical Oncology (ESMO) recently held its annual conference from October 20 – 24, 2023 in Madrid, Spain. ESMO represents one of the largest gatherings of the international oncology community, and this year’s meeting had over 30,000 registered attendees from around the world.  Though October 19th brought record rainfall to Madrid, breaking a 100-year record, the rain in Spain didn’t dampen the palpable excitement of this year’s meeting. This was an especially…

What Is a Clinical Trial

What Is a Clinical Trial

Lung cancer clinical trials are carefully designed research studies to evaluate and learn more about new drugs and treatments. They give people the ability to participate in lung cancer research and access to new treatments that otherwise may not be available to them, all under the close supervision of medical experts. 

Watch Recorded Expert Sessions From ILCSC

Watch Recorded Expert Sessions From ILCSC

The International Lung Cancer Survivorship Conference (ILCSC) is a free virtual educational conference for people with lung cancer, caregivers, and advocates. The 2023 conference was held September 22-23.  The recorded sessions from this conference are available to registered participants through December 21, 2023, at www.lungevity.org/ilcsc. If you did not register for the conference but would like to view the recordings, you may still register for free access. The recordings are…

The Latest Lung Cancer Science: Highlights of WCLC 2023

The Latest Lung Cancer Science: Highlights of WCLC 2023

I had the privilege of attending the 2023 World Conference on Lung Cancer (WCLC) in Singapore with my colleague Dr. Bellinda King-Kallimanis. WCLC, the world's largest meeting dedicated to lung cancer and other thoracic malignancies, is an excellent forum for learning about the latest research into the early detection and treatment of lung cancer. Apart from the science, it was inspiring to see fellow advocates and network with brilliant researchers, all razor-focused on improving the outcomes…

Lung Cancer and NCCN Guidelines: What They Are and Why They Matter

Lung Cancer and NCCN Guidelines: What They Are and Why They Matter

In this expert meetup session, Carlin Callaway will review the National Comprehensive Cancer Network’s (NCCN’s)  Non-Small Cell Lung Cancer (NSCLC) Guidelines and discuss how they are applicable to patient care. Participants will be able to ask general questions and engage in meaningful conversation.An expert in the field, Carlin Callaway, DNP, RN, ACNP-BC, ACNS-BC, AOCNP is Assistant Professor and the Lead Medical Oncology Advanced Practice Provider at the University of Colorado Cancer…

Be Part of the Largest Lung Cancer Event in the Nation

Be Part of the Largest Lung Cancer Event in the Nation

November is Lung Cancer Awareness Month, when the lung cancer community gathers to raise awareness for this disease and stand together – unified and strong. You can get involved in raising awareness about lung cancer by joining LUNGevity on Saturday, November 4, 2023, for our nationwide walk, Breathe Deep TOGETHER. Thousands of people from across the country, coming together in a singular event, is a powerful way to make our voices heard and increase the visibility of lung cancer.Together…

Transportation to Treatment

Transportation to Treatment

At some point, transportation to appointments becomes a challenge for everyone. Whether it be the cost, time commitment, or finding reliable transportation, we share some tips for overcoming or avoiding these issues when they arise.

Decentralized Trials: Bringing Clinical Trials Closer to the Patient

Decentralized Trials: Bringing Clinical Trials Closer to the Patient

While participating in clinical trials can provide substantial benefits to people with lung cancer, the resources required to do so may pose significant hurdles, especially to those who don’t live close to where trials are held, such as academic medical centers or major oncology network sites. Decentralized clinical trials remove some hurdles to trial participation for patients and are thus important for improving trial access for larger and more diverse groups of people. The U.S. Food and Drug…